학술논문

Genomic reconstruction of the SARS-CoV-2 epidemic in England
Document Type
article
Author
Robson, Samuel CConnor, Thomas RLoman, Nicholas JGolubchik, TanyaMartinez Nunez, Rocio TBonsall, DavidRambaut, AndrewSnell, Luke BLudden, CatherineCorden, SallyNastouli, EleniNebbia, GaiaLythgoe, KatrinaTorok, M EsteeGoodfellow, Ian GPrieto, Jacqui ASaeed, KordoHoulihan, CatherineFrampton, DanHamilton, William LWitney, Adam ABucca, GiseldaPope, Cassie FMoore, CatherineThomson, Emma CHarrison, Ewan MSmith, Colin PRogan, FionaBeckwith, Shaun MMurray, AbigailSingleton, DawnEastick, KirstineSheridan, Liz ARandell, PaulJackson, Leigh MGonçalves, SóniaFairley, Derek JLoose, Matthew WWatkins, JoanneMoses, SamuelNicholls, SamBull, MatthewSmith, Darren LAanensen, David MAggarwal, DineshShepherd, James GCurran, Martin DParmar, SurendraParker, Matthew DWilliams, CatrynGlaysher, SharonUnderwood, Anthony PBashton, MatthewPacchiarini, NicoleLoveson, Katie FByott, MatthewCarabelli, Alessandro MTempleton, Kate Ede Silva, Thushan IWang, DennisLangford, Cordelia FGunson, Rory NCottrell, SimonO’Grady, JustinKwiatkowski, DominicLillie, Patrick JCortes, NicholasMoore, NathanThomas, ClaireBurns, Phillipa JMahungu, Tabitha WLiggett, StevenBeckett, Angela HHolden, Matthew TGLevett, Lisa JOsman, HusamHassan-Ibrahim, Mohammed OSimpson, David AChand, MeeraGupta, Ravi KDarby, Alistair CPaterson, StevePybus, Oliver GVolz, Erikde Angelis, DanielaRobertson, David LPage, Andrew JBassett, Andrew RWong, NickTaha, YusriErkiert, Michelle JSpencer Chapman, Michael HDewar, RebeccaMcHugh, Martin PMookerjee, SiddharthAplin, StephenHarvey, MatthewSass, TheaUmpleby, HelenWheeler, Helen
Source
Nature. 600(7889)
Subject
Genetics
Prevention
Emerging Infectious Diseases
Infectious Diseases
Lung
Good Health and Well Being
Amino Acid Substitution
COVID-19
England
Epidemiological Monitoring
Genome
Viral
Genomics
Humans
Molecular Epidemiology
Mutation
Quarantine
SARS-CoV-2
Spatio-Temporal Analysis
Spike Glycoprotein
Coronavirus
Wellcome Sanger Institute COVID-19 Surveillance Team
COVID-19 Genomics UK (COG-UK) Consortium*
General Science & Technology
Language
Abstract
The evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus leads to new variants that warrant timely epidemiological characterization. Here we use the dense genomic surveillance data generated by the COVID-19 Genomics UK Consortium to reconstruct the dynamics of 71 different lineages in each of 315 English local authorities between September 2020 and June 2021. This analysis reveals a series of subepidemics that peaked in early autumn 2020, followed by a jump in transmissibility of the B.1.1.7/Alpha lineage. The Alpha variant grew when other lineages declined during the second national lockdown and regionally tiered restrictions between November and December 2020. A third more stringent national lockdown suppressed the Alpha variant and eliminated nearly all other lineages in early 2021. Yet a series of variants (most of which contained the spike E484K mutation) defied these trends and persisted at moderately increasing proportions. However, by accounting for sustained introductions, we found that the transmissibility of these variants is unlikely to have exceeded the transmissibility of the Alpha variant. Finally, B.1.617.2/Delta was repeatedly introduced in England and grew rapidly in early summer 2021, constituting approximately 98% of sampled SARS-CoV-2 genomes on 26 June 2021.